Skip to Content

Notice

Memorandum of Understanding Between the Maryland Department of Health and Mental Hygiene and the Food and Drug Administration

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Maryland Department of Health and Mental Hygiene and the Food and Drug Administration. The purpose is to set forth conditions for the utilization of Maryland Medicaid data for the study entitled “Compliance with Liver Testing Labeling Guidelines by Health Care Providers.”

DATES:

The agreement became effective December 12, 2000.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Katrina S. Garry, Center for Drug Evaluation and Research (HFD-400), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-3192.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

Start Signature

Dated: June 29, 2001.

Margaret M. Dotzel,

Associate Commissioner for Policy.

End Signature Start Printed Page 35647

Start Printed Page 35648

Start Printed Page 35649

Start Printed Page 35650

End Supplemental Information

BILLING CODE 4160-01-C

[FR Doc. 01-16988 Filed 7-5-01; 8:45 am]

BILLING CODE 4160-01-C